Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Ferrologix Inc in August, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR003048-01 | Phase I | 225,000 | August 20, 2019 | |||||||
A SBIR Phase I contract was awarded to Ferrologix Inc in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL149552-01 | Phase I | 225,000 | September 20, 2019 | |||||||
A SBIR Phase I contract was awarded to Ferrologix Inc in August, 2019 for $323,578.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR002701-01 | Phase I | 323,578 | August 27, 2019 | |||||||
A SBIR Phase II contract was awarded to Ferrologix Inc in September, 2020 for $920,268.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA228844-02 | Phase II | 920,268 | September 8, 2020 | |||||||
A SBIR Phase I contract was awarded to Ferrologix Inc in June, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA228844-01A1 | Phase I | 225,000 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Ferrologix Inc for $149,931.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N93019C00033 | Phase I | 149,931 | ||||||||
A SBIR Phase I contract was awarded to Ferrologix Inc for $398,001.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91020C00029 | Phase I | 398,001 | ||||||||
A SBIR Phase I contract was awarded to Ferrologix Inc in September, 2017 for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001910-01A1 | Phase I | 150,000 | September 5, 2017 | |||||||
A SBIR Phase I contract was awarded to Ferrologix Inc in June, 2017 for $225,000.0 USD from the National Science Foundation. | SBIR | 1721432 | Phase I | 225,000 | June 15, 2017 | |||||||
A SBIR Phase II contract was awarded to Ferrologix Inc in February, 2023 for $921,412.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM149063-01 | Phase II | 921,412 | February 1, 2023 |